Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

510(k) Premarket Notification
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back To Search Results
Device Classification Name Classifier, Prognostic, Recurrence Risk Assessment, Rna Gene Expression, Breast Cancer
510(k) Number K210973
Device Name MammaPrint FFPE NGS Kit
Applicant
Agendia Inc.
22 Morgan
Irvine,  CA  92618
Applicant Contact Marcelo Trevino
Correspondent
Agendia Inc.
22 Morgan
Irvine,  CA  92618
Correspondent Contact Marcelo Trevino
Regulation Number866.6040
Classification Product Code
NYI  
Date Received03/31/2021
Decision Date 09/08/2022
Decision Substantially Equivalent (SESE)
Regulation Medical Specialty Immunology
510k Review Panel Pathology
Summary Summary
FDA Review Decision Summary
Type Traditional
Reviewed by Third Party No
Combination Product No
Predetermined Change
Control Plan Authorized		 No
-
-